Medicare's Hospital Value-Based Purchasing Program Values Quality over QALYs.
Edward C NortonJun LiAnup DasAndrew M RyanLena M ChenPublished in: Medical decision making : an international journal of the Society for Medical Decision Making (2021)
Medicare's Hospital Value-Based Purchasing Program (HVBP) is the first national pay-for-performance program to combine measures of quality of care with a measure of episode spending. We estimated the implicit tradeoffs between mortality reduction and spending reduction. To earn points in HVBP, a hospital can either lower mortality or reduce spending, creating a tradeoff between the 2 measures. We analyzed the quality performance and earned points of 2814 hospitals using publicly available data. We then quantified the tradeoffs between spending and mortality in terms of quality-adjusted life-years (QALYs). If incentives in the program were balanced, then the tradeoff between spending and QALYs should be comparable with those of high-value health interventions, roughly $50,000 to $200,000 per QALY. Instead, the tradeoff in HVBP was about $1.2 million per QALY. HVBP overvalues improvements in quality of care relative to spending reductions. We propose 2 possible policy adjustments that could improve incentives for hospitals to deliver high-value care.
Keyphrases
- quality improvement
- healthcare
- palliative care
- cardiovascular events
- public health
- risk factors
- mental health
- affordable care act
- emergency department
- smoking cessation
- physical activity
- adverse drug
- artificial intelligence
- pain management
- big data
- health information
- data analysis
- men who have sex with men
- human immunodeficiency virus
- health insurance
- climate change
- human health
- antiretroviral therapy